UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in AXSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,129,354
+$15,083,107 QoQ
Shares Held
127,178
+34.0% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 500 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. AXSM ranks #24 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,129,354 | 127,178 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,046,247 | 94,937 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,935,154 | 87,249 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,528,618 | 86,691 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,998,799 | 134,101 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,734,650 | 74,892 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $4,877,086 | 57,642 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,288,054 | 47,714 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,523,534 | 56,193 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,301,511 | 28,841 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,388,414 | 30,009 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,404,213 | 34,400 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,784,641 | 24,835 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,531,821 | 24,835 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,078,961 | 26,954 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,115,632 | 25,003 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $845,164 | 22,067 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $950,271 | 22,959 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $867,389 | 22,959 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $756,727 | 22,959 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,863,581 | 27,625 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,406,836 | 24,847 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,203,191 | 27,043 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,971,701 | 27,673 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,232,091 | 27,128 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,087,943 | 18,493 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||